As we move into 2025, many companies are beginning the drug development journey. Whether you’re starting a new project or scaling up an existing one, it’s crucial to have the right strategies in place before you dive into the complexities of the development process.

While every project is unique, there are common challenges and best practices that can help ensure a smoother, more successful development path. Here are some key pre-development strategies to consider for your drug development project in 2025 that can be done in progressive phases.

1. Focus on Process Robustness Early On

One of the biggest mistakes companies make is rushing the early stages of drug development. While speed is important, it should never come at the expense of quality. Cutting corners in the beginning often leads to long-term headaches, particularly when it comes to process scalability and reliability.

Investing in the right processes and analytical capabilities upfront can save significant time and money in the future. For instance, developing a robust, scalable manufacturing process that can handle phase one and phase two clinical trials will pay off long-term. While it may seem tempting to focus solely on generating material for early toxicology studies, taking the time to do some cost-effective process optimization ensures better outcomes as your project progresses while balancing the costs of development.

2. Don’t Skip Key Early-Stage Studies

During the preclinical phase, many projects encounter unexpected issues due to insufficient understanding of the solid-state properties of the drug substance. Polymorphs and salt forms, which can significantly impact the solubility and bioavailability of a compound, are often overlooked or pushed too late in the development process. Skipping these studies early on can lead to serious challenges later when the drug is already in clinical trials.

By conducting thorough solid-state screening early in the process, you can avoid the need to redo the work that was already performed. If these studies are skipped, you risk encountering different polymorphs at larger scales, stability, and formulation issues that can delay development and have significant costs to your clinical trials and overall program.

3. Select Your Route and Chemistry with Long-Term Goals in Mind

Route selection is one of the most critical decisions you’ll make in the early stages of drug development. Many companies face challenges when they attempt to use a chemistry route developed elsewhere, often in countries with different equipment or manufacturing standards. When a route chosen for scalability or efficiency, it can lead to poor yields, inconsistent results, and costly lead times.

It’s essential to be open to modifying the medicinal chemistry route if needed to ensure it is both reproducible and scalable for later-stage trials. In many cases, the chemistry used in early development is not the same as what will be needed for larger-scale production, so having a flexible, process-driven mindset early on can prevent a lot of future setbacks.

4. Pay Close Attention to Impurities and Control Strategies

Managing impurities in early drug development can be a challenging but essential aspect of the process. Understanding the types of impurities generated during synthesis, as well as their potential effects on safety and efficacy, is key to establishing a solid control strategy. This understanding helps ensure that your process remains consistent and meets regulatory requirements throughout development.

Investing in analytical capabilities such as NMR and LCMS, early on during process development can provide critical insights into the overall impurity profiles and control strategies of your compound early in the process. Identifying and addressing impurity issues early not only improves the overall quality of your drug but also ensures smoother progression and control through the regulatory approval process.

5. Consider the Environmental and Scalability Impacts of Your Process

In today’s world, environmental sustainability is an increasingly important consideration in drug development. Not only is it essential for meeting regulatory expectations and market demands, but a greener process can also improve the overall efficiency and cost of production. Evaluating how to minimize waste, reduce energy consumption, and streamline processes can help you avoid costly inefficiencies as your project moves forward.

Additionally, scalability should be a key consideration in every decision you make. Ensure that the processes you develop during the early phases of your project are designed with the long-term goal of scaling up production. This foresight is particularly important as you transition from preclinical to clinical trials, where the quantity and consistency of your drug substance become even more critical.

6. Plan for Onshoring and Process Transfers

As the industry continues to shift towards onshoring and reshoring manufacturing capabilities, it’s crucial to consider how your process will transition from international facilities back to the U.S. If your process has been developed with specific equipment or conditions that are not easily replicated elsewhere, you may face difficulties during the transfer phase.

Ensuring that your process is designed to be flexible and adaptable to different manufacturing environments can save you significant time and money in the future. Starting this process early and addressing any potential roadblocks before they become major issues will ease the transition when it comes time to scale or shift production locations.

7. Invest in Strong Analytical Development from Day One

Strong analytical development is essential for the successful progression of any drug development project. From the very beginning, invest in the right analytical tools and technical team to understand your compound’s properties, detect impurities, and refine your process. Early and continuous analytical support ensures that any challenges related to purity, stability, and other quality concerns are addressed before they become insurmountable obstacles in later phases due to insufficient method development.

Be Prepared and Plan Ahead with Olon USA in 2025

Drug development is a complex, long-term process that requires careful planning, flexibility, and foresight. By addressing key aspects of the process early on, such as route selection, process optimization, impurity control, great method development, scalability, and great solid-state studies, you can minimize delays and maximize the chances of success as your project moves forward through all clinical phases.

In 2025, as the landscape continues to evolve, it’s more important than ever to take a proactive approach. With the right strategies and expert support, your drug development project can stay on track, meet its goals, and ultimately deliver value to patients and stakeholders alike. At Olon USA, we’re here to help you navigate this journey, providing the expertise and support needed to ensure a smooth and successful drug development process. Contact us today to get your project started!